Relmada Therapeutics, Inc. (RLMD)

CIK 1553643 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Relmada Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001213900-26-098969
Sep 11, 202640001213900-26-098970
Sep 8, 20268-K0001213900-26-097851
Aug 14, 2026SCHEDULE 13G/A0002050709-26-000025
Aug 6, 202610-Q0001213900-26-086151
Aug 6, 20268-K0001213900-26-086190
Jul 29, 2026SCHEDULE 13G0002012383-26-002872
Jul 28, 20268-K0001213900-26-082007
Jun 22, 2026SCHEDULE 13G0001104659-26-076490
Jun 18, 2026S-80001213900-26-070097
Jun 9, 2026SCHEDULE 13G0001738048-26-000066
May 28, 20268-K0001213900-26-062184
May 13, 2026S-3ASR0001213900-26-055901
May 13, 2026SCHEDULE 13G/A0000919574-26-002929
May 12, 202610-Q0001213900-26-055059
May 12, 20268-K0001213900-26-055164
May 4, 2026SCHEDULE 13G0001831942-26-000017
Apr 17, 2026DEF 14A0001213900-26-045192
Apr 17, 2026DEFA14A0001213900-26-045194
Apr 9, 2026EFFECT9999999995-26-001136
Apr 9, 2026424B30001213900-26-042007
Apr 6, 2026PRE 14A0001213900-26-040498
Apr 3, 2026S-30001213900-26-039967
Mar 20, 20268-K0001213900-26-032403
Mar 19, 202610-K0001213900-26-031862